Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: Searching for the best risk marker by mult.variate modeling

被引:217
作者
Tripepi, G
Mallamaci, F
Zoccali, C
机构
[1] CNR, Reggio Di Calabria, Italy
[2] Inst Biomed Clin Epidemiol & Physiopathol Renal D, Reggio Di Calabria, Italy
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷
关键词
D O I
10.1681/ASN.2004110972
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Inflammation is a major risk factor for mortality and cardiovascular (CV) complications in patients with ESRD. The predictive value of C-reactive protein (CRP) of the main proinflammatory cytokines (IL-10, IL-6, IL-18, and TNF-alpha) and of two adhesion molecules (intercellular adhesion molecule-1 and vascular cell adhesion molecule-1) in 217 dialysis patients was compared. Serum IL-6 and CRP added significant prediction power to the multivariate Cox model of all-cause death, and the gain in the prediction power attributable to IL-6 was approximately two times higher than that of CRP. Patients in the third tertiles of serum IL-6 and CRP had a relative risk of all-cause mortality 2.5 and 1.8 times higher than those in the first corresponding tertiles, and there was no statistical difference between these two relative risks. The gain in prediction power associated with TNF-alpha, IL-1 beta, IL-18, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 was of small degree (P = NS). Similarly, serum IL-6 added the highest prediction power to the CV death model, and the IL-6 attributable gain was approximately two times higher than that of serum CRP. However, the risk estimate for CV mortality of patients with high serum IL-6 did not differ significantly from that of patients with high serum CRP. IL-6 adds significantly greater predictive power for all-cause and CV death to statistical models based on traditional and nontraditional risk factors in ESRD patients. However, the risk estimate by CRP being reasonably close to that of IL-6, CRP may be a cheap alternative to IL-6 in clinical practice.
引用
收藏
页码:S83 / S88
页数:6
相关论文
共 30 条
  • [1] In-vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure
    Akahoshi, T
    Kobayashi, N
    Hosaka, S
    Sekiyama, N
    Wada, C
    Kondo, H
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (12) : 2244 - 2249
  • [2] Interleukin-18 and the risk of coronary heart disease in European men -: The Prospective Epidemiological Study of Myocardial Infarction (PRIME)
    Blankenberg, S
    Luc, G
    Ducimetière, P
    Arveiler, D
    Ferrières, J
    Amouyel, P
    Evans, A
    Cambien, F
    Tiret, L
    [J]. CIRCULATION, 2003, 108 (20) : 2453 - 2459
  • [3] Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina
    Blankenberg, S
    Tiret, L
    Bickel, C
    Peetz, D
    Cambien, F
    Meyer, J
    Rupprecht, HJ
    [J]. CIRCULATION, 2002, 106 (01) : 24 - 30
  • [4] Inflammatory markers and onset of cardiovascular events - Results from the Health ABC study
    Cesari, M
    Penninx, BWJH
    Newman, AB
    Kritchevsky, SB
    Nicklas, BJ
    Sutton-Tyrrell, K
    Rubin, SM
    Ding, JZ
    Simonsick, EM
    Harris, TB
    Pahor, M
    [J]. CIRCULATION, 2003, 108 (19) : 2317 - 2322
  • [5] COLLET D, 1994, MODELLING SURVIVAL D, P72
  • [6] Fantuzzi G, 1996, J IMMUNOL, V157, P291
  • [7] Anthropometric measures, cytokines and survival in haemodialysis patients
    Kimmel, PL
    Chawla, LS
    Amarasinghe, A
    Peterson, RA
    Weihs, KL
    Simmens, SJ
    Alleyne, S
    Burke, HB
    Cruz, I
    Veis, JH
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (02) : 326 - 332
  • [8] Immunologic function and survival in hemodialysis patients
    Kimmel, PL
    Phillips, TM
    Simmens, SJ
    Peterson, RA
    Weihs, KL
    Alleyne, S
    Cruz, I
    Yanovski, JA
    Veis, JH
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (01) : 236 - 244
  • [9] C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-α in the prognostic classification of unstable angina pectoris
    Koukkunen, H
    Penttilä, K
    Kemppainen, A
    Halinen, M
    Penttilä, I
    Rantanen, T
    Pyörälä, K
    [J]. ANNALS OF MEDICINE, 2001, 33 (01) : 37 - 47
  • [10] MACKIEWICZ A, 1991, J IMMUNOL, V146, P3032